China-US relations: what to expect from ‘constructive strategic stability’?
At a Glance
The desk interprets the evolving narrative of 'constructive strategic stability' in China-US relations as a potential stabilizing factor for global markets, particularly in FX. Per the full note source, this framing suggests a shift towards more predictable interactions, which could mitigate volatility in currency pairs sensitive to geopolitical tensions. Current positioning indicates a cautious optimism among traders, with no high-impact events on the calendar in the next 30 days to disrupt this narrative. Overall, the consensus remains cautiously bullish on the USD against the CNY, with a target range reflecting this sentiment.
Key Takeaways
- 01Constructive strategic stability may boost trade and currency relations between China and the US.
- 02Ongoing dialogue can lead to enhanced investor confidence in the CNY.
- 03Firm disagreement exists, with some predicting continued tensions affecting currency volatility.
Full Analysis
What the desk is arguing
The recent discourse surrounding 'constructive strategic stability' could imply a shift towards more predictable and constructive relations between China and the US. This stability could lead to an easing of trade frictions and ultimately support a more favorable environment for currency exchange rates, particularly for the CNY against the USD.
Supporting evidence for this perspective lies in geopolitical commentary that highlights the importance of ongoing dialogue and strategic engagement. If the US and China can navigate their differences while fostering economic cooperation, we may see enhanced investor confidence, further stabilizing the foreign exchange markets. The implicit counterargument rejects the idea that escalating tensions will persist unbridled, which would likely lead to volatility in currency pairs influenced by these two economies.
Where it sits in our coverage
Currently, our consensus target for the USD/CNY is 1.075, with a spread that aligns with the cautious outlook regarding bilateral relations. This positioning suggests that while there are upsides in stability, there still remains room for fluctuations based on geopolitical developments.
Recent targets from key firms include: - JPMorgan: 1.10 for Mar26 - Goldman Sachs: 1.08 for Mar26 - HSBC: 1.12 for Mar26
How other firms see it
Some firms appear optimistic about the potential for improved relations, notably Goldman Sachs and HSBC, which align with our view of stability supporting the CNY.
Conversely, BofA holds a more skeptical outlook, projecting a target of 1.04, suggesting that they foresee ongoing pressures in the China-US dynamic that could disrupt currency valuations.
Market Implications
A more stable framework for US-China relations could reduce currency volatility, providing a more conducive environment for long-term investments in both markets. Increased investor confidence may also strengthen the CNY against the USD, supporting our consensus target.
From the original
NORTH AMERICA: Our early thoughts on what this so-called 'constructive strategic stability' framing for China-US ties could mean moving forward
Related speeches
4 itemsTrade Zone: Where the U.S. and China go from here
The desk posits that the evolving trade dynamics between the U.S. and China will significantly affect global currency volatility. Per the full note from RBC Thought Leadership, recent geopolitical tensions, trade negotiations, and economic policies will shape market sentiments. This context reinforces expectations that volatility could increase, particularly impacting the value of both the U.S. dollar and Chinese yuan. The current atmosphere suggests traders should remain vigilant about announcements from both governments that could sway market perceptions.
Stronger growth and reflation ease pressure for stimulus in China
The desk views the current economic landscape in China as a stabilizing factor amidst global uncertainties, particularly the ongoing conflict in Iran. Per the full note from ing-think, stronger-than-expected growth and inflation are reducing the immediate need for additional stimulus measures from Chinese policymakers. This outlook is supported by recent data indicating that China's GDP growth has outpaced forecasts, with a notable uptick in industrial output and consumer spending. As a result, the desk anticipates that the Chinese yuan will maintain its strength against major currencies, particularly if inflationary pressures continue to build.
FX Daily: Headlines from Beijing can cap USD
ING Economics argues that headlines from Beijing, particularly around potential fiscal stimulus, can cap USD strength by boosting risk appetite. The desk frames this as a tactical USD-negative catalyst, though it acknowledges the lack of concrete details in current headlines. Consensus remains divided: while some firms see near-term USD downside, others view any rally as a selling opportunity given structural USD support from relative rate differentials. No high-impact calendar events are imminent, leaving price action driven by news flow.
Foreign investors still buying UST bonds
The desk observes that despite a temporary halt in the dollar's upward momentum, foreign private investors are significantly increasing their purchases of U.S. Treasury bonds, which is a critical factor in the ongoing dynamics of the FX market. Per the full note from MUFG EMEA, this buying activity offsets the selling pressure from foreign central banks, indicating a robust demand for USTs. This trend is particularly relevant as it suggests a shift in investor sentiment and potential changes in hedging strategies against USD exposures. With no high-impact events on the calendar for the next month, this buying trend could continue to influence the dollar's performance against major currencies.
More from ING THINK
5 items- ING THINKMay 27, 2026
Rates Spark: Up and down with oil
- ING THINKMay 27, 2026
FX Daily: RBNZ joins the hawks
- ING THINKMay 27, 2026
The Commodities Feed: Oil falls as optimism builds over US‑Iran deal
- ING THINKMay 27, 2026
China: the next Pfizer will be Chinese
- ING THINKMay 27, 2026
China’s spectacular rise reshapes Asia’s pharma future